ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023
Identification and Characterization of CD8
Abstract read
In one paragraph
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- In vivo CAR-cell therapy: current challenges and emerging therapeutic advances.Molecular biomedicine · 2026Review
- Age-independent and targetable transcription factor networks regulating CD8Cell reports · 2026Article
- Ten-Eleven Translocation Family Proteins: Structure, Biological Functions, Diseases, and Targeted Therapy.MedComm · 2025Review
- Cytotoxic Molecules as Potential Biomarkers for Active and Inactive Systemic Lupus Erythematosus.Biomedicines · 2025Article
- Review
- Enhancing the treatment potential of IL-17 antagonism in lupus nephritis: finding the right partner.Frontiers in immunology · 2025Review
- CD38 deficiency leads to a defective short-lived transcriptomic response to chronic graft-versus-host disease induction, involving purinergic signaling-related genes and distinct transcriptomic signatures associated with lupus.Frontiers in immunology · 2025Article
- Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma.Genome medicine · 2024Article
- Identification of immune subsets with distinct lectin binding signatures using multi-parameter flow cytometry: correlations with disease activity in systemic lupus erythematosus.Frontiers in immunology · 2024Article
- Single-cell mass cytometry in immunological skin diseases.Frontiers in immunology · 2024Review
- Identification and Characterization of CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Lulu ZhangDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital and School of Biomedical Engineering, Shanghai, 200030, China.ORCID 0000-0002-8805-8121
Fang DuDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital and School of Biomedical Engineering, Shanghai, 200030, China.ORCID 0000-0002-9614-9517
Qiqi JinKey Laboratory of Systems Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, 200031, China.
Li SunDepartment of Rheumatology and Immunology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Boqian WangDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital and School of Biomedical Engineering, Shanghai, 200030, China.
Ziyang TanScience for Life Laboratory, Department of Women's and Children's Health, Karolinska Institutet, Solna, 17121, Sweden.
Xinyu MengState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200001, China.
Baozhen HuangDepartment of Chemical Pathology, Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China.
Yifan ZhanDrug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, 200131, China.
Wenqiong SuState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200001, China.ORCID 0000-0003-4914-346X
Rui SongDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital and School of Biomedical Engineering, Shanghai, 200030, China.
Chunmei WuDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital and School of Biomedical Engineering, Shanghai, 200030, China.
Luonan ChenKey Laboratory of Systems Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, 200031, China.
Xiaoxiang ChenDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital and School of Biomedical Engineering, Shanghai, 200030, China.
Xianting DingDepartment of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital and School of Biomedical Engineering, Shanghai, 200030, China.ORCID 0000-0002-1549-3499
Funding
JST Moonshot R&D JPMJMS2021National Key R&D Program of China 2022YFA1004800National Key R&D Program of China 2022YFC2601700National Natural Science Foundation of China 12131020National Natural Science Foundation of China 22077079National Natural Science Foundation of China 31930022National Natural Science Foundation of China 81871448National Natural Science Foundation of China T2122002National Natural Science Foundation of China T2341007National Natural Science Foundation of China T2350003Shanghai Clinical Medical Research Center Project 19MC1910800Shanghai Jiao Tong University Projects 2020SJTU-HUJIShanghai Jiao Tong University Projects 23X010300584Shanghai Jiao Tong University Projects Agri-X20200101Shanghai Jiao Tong University Projects YG2019ZDA20Shanghai Jiao Tong University Projects YG2021ZD19Shanghai Municipal Education Commission Projects 21SG10Shanghai Municipal Education Commission Projects ZXWF082101Shanghai Municipal Health Commission Project 2019CXJQ03Shanghai Municipal Science and Technology Projects 18430760500Shanghai Municipal Science and Technology Projects 2017SHZDZX01Shanghai Municipal Science and Technology Projects 22Z510202478Shanghai Municipal Science and Technology Projects 23YF1425600Shanghai Sailing Program 20YF1425800
Abstract
Systemic Lupus Erythematosus (SLE) etiopathogenesis highlights the contributions of overproduction of CD4
Indexed as
CD4-Positive T-LymphocytesLupus Erythematosus, SystemicBiomarkersCD8-Positive T-LymphocytesDisease ProgressionHumansLeukocytes, MononuclearReceptors, CXCR3BiomarkersCXCR3 protein, humanReceptors, CXCR3dynamic network biomarkermass cytometrysingle-cell RNA sequencingsystemic lupus erythematosus
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.